Recent Progress in Blood–Brain Barrier and Blood–CSF Barrier Transport Research: Pharmaceutical Relevance for Drug Delivery to the Brain-Reference-Cited by-同舟云学术

Recent Progress in Blood–Brain Barrier and Blood–CSF Barrier Transport Research: Pharmaceutical Relevance for Drug Delivery to the Brain

Published:2013-11-13 Issue: Volume: Page:23-62
ISSN:2210-7371
Container-title:Drug Delivery to the Brain
language:
Short-container-title:

Author:

Tachikawa Masanori,Uchida Yasuo,Ohtsuki Sumio,Terasaki Tetsuya

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4614-9105-7_2

Reference199 articles.

1. Abbott NJ, Romero IA (1996) Transporting therapeutics across the blood-brain barrier. Mol Med Today 2:106–113

2. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41–53

3. Adkison KD, Shen DD (1996) Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter. J Pharmacol Exp Ther 276:1189–1200

4. Agarwal S, Sane R, Gallardo JL, Ohlfest JR, Elmquist WF (2010) Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux. J Pharmacol Exp Ther 334:147–155

5. Agarwal S, Uchida Y, Mittapalli RK, Sane R, Terasaki T, Elmquist WF (2012) Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice. Drug Metab Dispos 40:1164–1169

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood–Brain Barrier Model Derived from Hematopoietic Stem Cells;Cells;2022-12-08

2. The development and function of the brain barriers – an overlooked consideration for chemical toxicity;Frontiers in Toxicology;2022-10-18

3. Construction and Functional Evaluation of a Three-Dimensional Blood–Brain Barrier Model Equipped With Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells;Pharmaceutical Research;2022-04-11

4. Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery;Pharmaceutical Research;2022-03-07

5. Blood-Arachnoid Barrier as a Dynamic Physiological and Pharmacological Interface Between Cerebrospinal Fluid and Blood;Drug Delivery to the Brain;2022